Tag: DECN

DECN Recap & More

Decision Diagnostics, Corp. DECN 

We began tracking DECN just under three weeks ago, back on the morning of March 19th. The stock caught our attention after announcing that it was working on a rapid-result COVID-19 test. Subsequent to that point in time, it was trading for as little as .056/share.

Yesterday, following another tag in our extended watchlist, and as an update on the company’s coronavirus test was provided (excerpt and link below), the stock reached some very impressive new highs. It’s not the first coronavirus related play we’ve scored on, and it won’t be the last.

DECN ran 216% intraday from .125 to a new high of .395. From our initially observed low from the week before last, the stock has now exhibited an upswing of 605%

Decision Diagnostics Corp. (OTC PINK:DECN) through its subsidiary Pharma Tech Solutions, Inc.  …announces today that the company has received the Pre-EUA Acknowledgement letter from the U.S. FDA for device (serial number) PEUA200232, GenViro Covid-19 Screening Kit. This grant by the FDA is a major milestone in our GenViro!™ Covid-19 test kit development (>>View Full PR)

Johnson & Johnson JNJ – Recap

After seeing success with a number of different targets within the JNJ chain over the past week and change, we rolled our potential strike prices up to the JNJ Weekly $140-142 Calls yesterday morning.

Being one of the lead candidates for potentially developing an effective COVID-19 vaccine, it puts JNJ in a somewhat unique position, as experts have repeatedly stated that the world cannot begin to fully recover until a viable vaccine is being widely administered sometime next year.

Our move to the $140-142 Calls proved prudent yesterday, as early activity provided the following intraday opportunities: 

JNJ Weekly $140-142 Calls
$140: .89-2.88 (+224%)
$141: .62-2.31 (+273%)
$142: .43-1.67 (+288%)
_____

Fresh Ideas:
LEVI 04/17 $12-13 Calls
SGH 04/17 $22.50-25 Calls 

Extended  Watchlist:
BIEI, MBRX PINS, BNGO, SONN, EFC, NYMT

Options Updates, Fresh Ideas

Options Updates
.
Johnson & Johnson JNJ – We initially made the longer-term call on the JNJ 09/18 $150-155 Calls at the beginning of last week, and yesterday morning as part of an update on those targets we also gave a more immediate idea with the JNJ Weekly $134-137 Calls. The markets absolutely ripped yesterday, and that catapulted both sets of ideas to new heights.


Here are the updated highs on last Monday’s September calls, as well as the single-session ranges on the weeklies:

09/18 $150-155 Calls
$150: 2.90-5.80 (+100%)
$155: 2.27-4.00 (+76%)

JNJ Weekly $134-137 Calls.
$134: 3.19-7.20 (+126%)
$135: 2.54-6.00 (+136%)
$136: 2.09-3.95 (+89%)

We would also like to roll up to include the Weekly $140-142 Calls on our watchlist.

______

SPDR S&P500 (ETF) SPY – We also signaled interest in a range of SPY calls in yesterday morning’s ;premarket report, highlighting the Weekly $258-260 Calls.

The bullish day for stocks across the board facilitated some very good moves in those three contract sets on the session. We expect these gains to be extended at the open, as the markets are gapping up once again this morning in early trading.

Weekly $258-260 Calls 
$258: 4.07-10.66 (+162%)
$259: 3.61-9.98 (+176%)
$260: 3.11-9.25 (+197%)

Extended  Watchlist:
CRON, TLRY, CGC, GUSH, BSGM, ALTD, HALB, DECN, NSPX, OZSC, 

APRN Blows its Lid & More

Blue Apron Holdings Inc. APRN

We provided readers with a set of stocks that we felt were uniquely built to weather the coronavirus storm in yesterday morning’s premarket report. APRN had already begun to rise a little bit prior to that, but yesterday’s huge session really sent it for a ride.

The stock registered as the number three top gainer on the NASDAQ for its performance, which saw it trade up from a low 8.70 and hit 19.49, which represents an intraday rise of 124%. As of this morning’s premarket trading, APRN has now hit 24.50, extending our total observed range in 24 hours to 182%

With people being urged to stay home as much as possible, and perhaps with a mandatory nationwide quarantine on the way, we would expect Blue Apron’s order volume to stay at what we can only imagine are all time highs. As far as how high the stock could run, that’s anyone’s guess, but we’ll be tracking it closely to find out.

Decision Diagnostics Corp. DECN

Certain stocks on the OTC have also been enjoying solid performances in relation to the coronavirus.  The company believes that its GenViro! COVID-19 “Rapid” Kit will be in high demand after the release of new FDA guidance allowing for near immediate distribution of kits with minimal red tape.

We had placed the stock in our extended watchlist in yesterday morning’s report, and were met with a very respectable intraday move from .118-.198, which works out to a gain of 68%

Fresh Options Ideas

GILD Weekly $79-81 Calls
WBA Weekly $52.50-54 Calls
HAL 04/03 $4-5.00 Calls